Pulmonary Disease Doctors in Greensboro, NC Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Dr. Rakesh Vishwanath Alva, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3511 W Market St Ste 100, Greensboro, NC 27403 Phone: 336-522-8999

Douglas Brent Mcquaid, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 520 N Elam Ave, Greensboro, NC 27403 Phone: 336-547-1801    Fax: 336-547-1828

Dr. Vineet Sood, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 520 N. Elam Ave, Greensboro, NC 27403 Phone: 336-547-1801    Fax: 336-547-1828

Dr. Wesam Gaber Yacoub, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 520 N Elam Ave, Lebauer Pulmonary, Greensboro, NC 27403 Phone: 336-547-1801    Fax: 336-547-1828

Adewale Olalere, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3511 W Market St Ste 100, Greensboro, NC 27403 Phone: 336-522-8999

News Archive

Human models could be way forward for assessing analgesic efficacy

Researchers say that human experimental pain models could be used to assess the clinical efficacy of analgesics in phase I clinical studies.

Label-Free Technologies Conference to be held in Amsterdam

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the Label-Free Technologies Conference to be held in Amsterdam, the Netherlands, 1-3 November 2012.

Revance Therapeutics raises $33M in Series E financing

Revance Therapeutics, Inc., a privately held specialty biopharmaceutical company developing novel botulinum toxin products for use in aesthetic and therapeutic indications, today announced that it has raised $33 million of its Series E growth financing.

New understanding of how neurogenesis occurs

Scientists at the Salk Institute for Biological Studies have identified a crucial cellular signal that controls the fate of stem cells in the brains of adult mice.

CARE invests $1.8 billion to reduce maternal mortality by 2015

Today the humanitarian organization CARE announced that it will invest $1.8 billion to expand its maternal, newborn and child health programs to more than 30 countries in five years. This investment will deepen CARE's commitment to the United Nations Millennium Development Goals (MDGs) aimed at reducing child and maternal mortality by 2015 and will support the United Nations Secretary General's Global Strategy on Women's and Children's Health, which will be unveiled at next week's MDG Summit.

Read more Medical News

› Verified 6 days ago